A randomized study of BAY 43-9006 in combination with doxorubicin vs doxorubicin in pts with advanced hepatocellular carcinoma
|Effective start/end date||3/15/05 → 10/31/07|
- BAYER CORP
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.